Virtue

Virtue is a purpose-built earliest-stage healthcare venture capital firm founded in 2021 and headquartered in Austin, Texas Understanding healthcare financial benchmarks helps founders navigate this. Founded by Sean Doolan and Emre Karatas, the firm manages $87 million across two funds — Fund I ($31.25M, closed 2021) and Fund II ($55.75M, closed January 2025) — and has built a concentrated portfolio of 26 companies.

Unlike generalist pre-seed funds that write small checks across many sectors, Virtue is laser-focused on healthcare. The firm backs founders who want to radically re-architect the healthcare value chain, with a particular appetite for non-traditional operators — founders who have lived the problem they are solving, not just studied it.

This guide covers Virtue's real investment thesis, their complete portfolio, typical check sizes, what they look for in founders, and how to approach them for funding.

Virtue's thesis is direct: back non-traditional founders who radically re-architect the healthcare value chain at the earliest possible stage. The firm does not invest in ideas that need more validation — they invest in founders who have already seen the problem up close and are building from lived experience. Understanding cash conversion cycles in healthcare is valuable for any founder.

The firm writes $500K–$2M checks and targets meaningful ownership. They typically aim to be the first institutional investor or the lead investor in a round, not a follower. The 7–10 day decision timeline is a feature, not a bug — Virtue moves fast because they know the best healthcare founders have options.

Sector coverage spans digital health, clinical AI, healthcare data infrastructure, pharmacy benefits, care delivery, and health insurance. The firm does not invest in biotech instruments or device hardware — their focus is software and services that sit on top of the healthcare system.

Geographic focus is national, but Austin-based roots give the firm strong connectivity to the growing Texas healthcare ecosystem — particularly medical groups, health systems, and emerging payer models in the state.

The concentrated portfolio strategy means Virtue can be deeply involved with each holding. The team leverages healthcare operational expertise for portfolio companies in hiring, regulatory navigation, and customer introductions.

Virtue closed its $55.75M Fund II in January 2025, signaling strong LP confidence in the team's strategy and the healthcare thesis. The fundraise came amid a challenging early-stage venture environment, particularly for sector-specific funds. Understanding understanding burn rate and runway is valuable for any founder.

With Fund II capital deployed, Virtue has accelerated its pace of new investments in 2025. The firm is actively seeing new companies across all four of its core theses: value-based care enablement, healthcare data infrastructure, clinical AI, and pharmacy benefits.

Portfolio companies are actively raising follow-on rounds from other top healthcare investors, demonstrating that Virtue's early conviction attracts downstream capital. The firm's network effect is visible in its portfolio — many founders refer other operators who are starting companies.

Virtue's Substack and public writings offer a transparent window into the firm's thinking on the healthcare market. Their posts on actuarial infrastructure, AI financial analysis for health systems, and value-based care economics reflect a team that thinks deeply about structural shifts, not just deal flow.

Virtue's portfolio spans 26 companies across healthcare technology, data, and care delivery. Below is a summary of their key holdings by sector.

Value-Based Care & Care Delivery Amae Health (value-based SMI care), RightSite Health (non-emergent ED diversion), Seen Health (modern PACE experience), Zocalo Health (integrated primary care delivery), Anna (NDBI for pediatric development).

Clinical AI & Documentation Dart Health (AI for clinical workloads), SmarterDX (clinical documentation integrity), Ryght AI (biopharma insights and analytics), Translucent (AI financial analyst for healthcare operators), Solstice Health (AI engine for life sciences marketing).

Healthcare Data Infrastructure Tuva Health (open source healthcare data transformation), Integral (healthcare data compliance), Hermes Health (unlocking identified data access), Standard Model Bio (multimodal foundation model for biomedicine), Prudentia Sciences (drug asset diligence and valuation).

Pharmacy & Benefits WriteWise (level-funded pharmacy insurance), LightSpun (automated claims administration and adjudication).

Health Insurance & Brokerage Gyde (AI-native health insurance brokerage).

Financial Infrastructure for Healthcare ValleySteer (AI-powered payment stack for healthcare), Mural Health (financial infrastructure for clinical trials).

Care Operations Clara (payroll for senior home care), HealthMC (precision coding at scale), ZoomLogi (cold chain logistics visibility), Hero Journey Club (gamified social and emotional skill development).

Women's Health & Precision Care Evvy (precision vaginal microbiome care and enterprise bioinformatics).

The portfolio is deliberately concentrated, allowing Virtue to provide deep operational support to each company rather than spreading expertise thin.

Virtue's founder criteria is distinctive: they look for operators who have worked inside the problem, not just adjacent to it. A clinical background, healthcare operational experience, or direct experience with the systemic failure being addressed carries more weight than typical founder credentials.

The firm explicitly backs non-traditional founders — meaning the best healthcare founders are not always those with Stanford CS backgrounds. They want entrepreneurs who have navigated the healthcare system as providers, administrators, or patients, and who are building to fix what they have experienced firsthand.

Virtue expects founders to have a clear view of the full healthcare value chain for their specific problem. This means understanding reimbursement dynamics, regulatory constraints, and the actual SaaS unit economics of delivering care — not just the technology layer.

Strong product intuition backed by early traction is valued over polished pitch decks. Virtue will probe whether the founder has tested assumptions with real users, whether the business model holds under real-world conditions, and whether the team can execute without constant guidance.

Cultural alignment with long-term partnership matters. Virtue invests early and holds meaningful stakes — they are not looking for a quick flip. Founders should understand that Virtue's involvement is designed to be deep, not passive.

The most effective path to Virtue is a warm introduction from a portfolio founder, a trusted healthcare investor, or a referrer who has direct experience with the firm's credibility in the ecosystem. Virtue's network effect means that founders who come recommended by the healthcare community get priority access.

The firm accepts cold submissions through their website at virtuevc.com, but the conversion rate from cold inbound is significantly lower than from warm-referred deals. If submitting cold, the pitch deck must immediately convey deep healthcare problem expertise and early evidence of traction.

Given the 7–10 day decision window, founders should come to the first meeting fully prepared. Virtue expects a clear articulation of the problem, the solution, the business model, and early traction metrics — without needing to walk through a lengthy deck.

Follow-up cadence after an initial meeting should be professional and consistent without being pushy. Virtue's fast decision timeline means there is rarely a long waiting period — if they are interested, you will know within two weeks.

Even if your current round does not result in an investment, building a relationship with Virtue can pay dividends in future fundraising rounds. The firm's network spans a large portion of the active healthcare investor ecosystem.

While Virtue invests at the earliest stage, they expect founders to have a firm grasp on the financial mechanics of their business. This means understanding burn rate, runway, SaaS unit economics, reimbursement timelines, and the path to breakeven or the next round.

Healthcare businesses in particular have complex financial architectures — reimbursement cycles, payer mix, and cost-of-care delivery are all variables that Virtue will probe. Founders who can speak fluently about these dynamics stand out.

A fractional CFO can help healthcare founders build investor-ready financial models, prepare for due diligence, and confidently discuss the economics of their business model. Professional financial infrastructure signals to investors that the founder is operating at a level commensurate with the capital they are raising.

Whether you are preparing to pitch Virtue or another leading healthcare investor, having professional financials and a clear financial narrative can set you apart. Our team has helped healthcare technology companies prepare investor materials that convey operational depth and financial credibility — the combination that early-stage healthcare investors like Virtue want to see.

Exploring other venture capital firms? Our comprehensive collection of VC firm reviews covers hundreds of investors across all stages and sectors.

Each review provides detailed information about investment criteria, portfolio companies, and tips for securing funding. Whether you are looking for seed-stage investors or growth equity firms, you will find valuable insights in our VC firm guides.

Finding the right investor for your startup is crucial to your success. Take the time to research potential investors and understand their investment thesis before reaching out.

Our guides cover major venture capital firms as well as emerging managers that may be a better fit for your company's specific needs and stage.